newsfilter
← Latest News
Business Wire·

PhaseBio Announces Topline Results From Phase 2b Trial for Bentracimab

Trial achieved primary reversal endpoint in healthy, older volunteers Safety and efficacy profile of bentracimab in the Phase 2b trial consistent with previously completed Phase 1 and Phase 2a trials Interim results from REVERSE-IT Phase 3 trial t